SMT	NN	O
C1100	NN	O
,	,	O
demonstrated	VBD	B-REL
significant	JJ	I-REL
disease	NN	I-REL
modifying	VBG	I-REL
effects	NNS	I-REL
in	IN	O
DMD	NNP	O
models	NNS	O

A	DT	O
new	JJ	O
drug	NN	O
for	IN	O
the	DT	O
muscle-wasting	JJ	O
disease	NN	O
Duchenne	NN	O
muscular	JJ	O
dystrophy	NN	O
has	VBZ	B-REL
shown	VBN	I-REL
significant	JJ	I-REL
benefits	NNS	I-REL
in	IN	O
mice	NNS	O

A	DT	O
drug	NN	O
that	WDT	O
can	MD	B-REL
boost	VB	I-REL
muscle	NN	O
strength	NN	O
in	IN	O
mice	NNS	O

longer	RB	O
duration	NN	O
of	IN	O
breast	NN	O
feeding	NN	O
-LRB-	-LRB-	O
at	IN	O
all	DT	O
or	CC	O
exclusively	RB	O
-RRB-	-RRB-	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
having	VBG	O
fewer	JJR	O
parent-rated	JJ	O
behavioural	NN	O
problems	NNS	O
in	IN	O
term	NN	O
children	NNS	O

longer	RB	O
duration	NN	O
of	IN	O
breast	NN	O
feeding	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
fewer	JJR	O
parent-rated	JJ	O
behavioural	NN	O
problems	NNS	O

Breastfeeding	VBG	O
for	IN	O
four	CD	O
months	NNS	O
or	CC	O
more	JJR	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
fewer	JJR	O
behavioural	JJ	O
problems	NNS	O
in	IN	O
children	NNS	O

MUMS	NNS	O
should	MD	O
breastfeed	VB	O
for	IN	O
at	IN	O
least	JJS	O
four	CD	O
months	NNS	O
to	TO	B-REL
avoid	VB	I-REL
having	VBG	I-REL
naughty	JJ	O
kids	NNS	O

Breastfeeding	VBG	O
leads	VBZ	B-REL
to	TO	I-REL
better	JJR	O
behaviour	NN	O
in	IN	O
children	NNS	O

Breastfed	JJ	O
children	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
better	JJR	I-REL
behaved	VBD	O

Breast-fed	JJ	O
babies	NNS	O
turn	VBP	B-REL
into	IN	O
better	JJR	O
behaved	VBD	O
children	NNS	O

Children	NNS	O
who	WP	O
are	VBP	O
breastfed	VBN	O
for	IN	O
four	CD	O
months	NNS	O
or	CC	O
more	JJR	O
develop	VB	B-REL
fewer	JJR	O
behaviour	NN	O
problems	NNS	O

coaching	NN	O
for	IN	O
the	DT	O
SAT	NNP	O
does	VBZ	B-REL
lead	VB	I-REL
to	TO	I-REL
a	DT	I-REL
significant	JJ	I-REL
improvement	NN	I-REL
in	IN	O
scores	NNS	O
over	IN	O
uncoached	JJ	O
peers	NNS	O

We	PRP	O
show	VBP	O
a	DT	B-REL
significant	JJ	I-REL
effect	NN	I-REL
in	IN	I-REL
score	NN	I-REL
improvement	NN	I-REL
for	IN	O
coached	VBN	O
students	NNS	O
over	IN	O
their	PRP$	O
uncoached	JJ	O
peers	NNS	O
in	IN	O
both	CC	O
the	DT	O
Math	NNP	O
andVerbal	NNP	O
subtests	NNS	O
of	IN	O
the	DT	O
examination	NN	O

Coaching	NN	O
has	VBZ	B-REL
a	DT	I-REL
`	``	O
significant	JJ	O
result	NN	O
'	''	O
on	IN	O
SAT	NNP	O
scores	NNS	O

...	:	O
human	JJ	O
orbital	JJ	O
volume	NN	O
volume	NN	O
significantly	RB	B-REL
increases	VBZ	I-REL
with	IN	I-REL
absolute	JJ	O
latitude	NN	O
...	:	O

...	:	O
we	PRP	O
demonstrate	VBP	O
a	DT	O
significant	JJ	B-REL
positive	JJ	I-REL
relationship	NN	I-REL
between	IN	O
absolute	JJ	O
latitude	NN	O
and	CC	O
human	JJ	O
orbital	JJ	O
volume	NN	O
...	:	O

...	:	O
the	DT	B-REL
farther	RBR	O
that	WDT	O
human	JJ	O
populations	NNS	O
live	VBP	O
from	IN	O
the	DT	O
equatoe	NN	O
,	,	O
the	DT	O
bigger	JJR	O
their	PRP$	O
brains	NNS	O
...	:	O

...	:	O
Northern	NN	O
brain	NN	O
is	VBZ	B-REL
actually	RB	I-REL
bigger	JJR	I-REL
than	IN	O
those	DT	O
of	IN	O
the	DT	O
south	NN	O
...	:	O

...	:	O
northerners	NNS	O
have	VBP	B-REL
bigger	JJR	I-REL
brains	NNS	O
...	:	O

...	:	O
northerners	NNS	O
have	VBP	B-REL
bigger	JJR	I-REL
brains	NNS	O
...	:	O

...	:	O
Northerners	NNS	O
really	RB	O
do	VBP	O
have	VB	B-REL
bigger	JJR	I-REL
brains	NNS	O
...	:	O

...	:	O
it	PRP	O
gives	VBZ	B-REL
you	PRP	I-REL
a	DT	O
bigger	JJR	O
brain	NN	O
...	:	O

...	:	O
northern	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
world	NN	O
have	VBP	B-REL
evolved	VBN	I-REL
bigger	JJR	O
brains	NNS	O
and	CC	O
larger	JJR	O
eyes	NNS	O
...	:	O

...	:	O
people	NNS	O
living	VBG	O
far	RB	O
north	RB	O
of	IN	O
the	DT	O
equator	NN	O
have	VBP	B-REL
developed	VBN	I-REL
bigger	JJR	O
eyes	NNS	O
-	:	O
and	CC	O
brains	NNS	O
...	:	O

when	WRB	O
laughter	NN	O
is	VBZ	O
elicited	VBN	O
,	,	O
pain	NN	O
thresholds	NNS	O
are	VBP	O
significantly	RB	B-REL
increased	VBN	I-REL

pain	NN	O
thresholds	NNS	O
are	VBP	B-REL
significantly	RB	I-REL
higher	JJR	I-REL
after	IN	O
laughter	NN	O
than	IN	O
in	IN	O
the	DT	O
control	NN	O
condition	NN	O

Having	VBG	O
a	DT	O
good	JJ	O
laugh	NN	O
with	IN	O
friends	NNS	O
really	RB	O
does	VBZ	B-REL
help	VB	I-REL
us	PRP	I-REL
to	TO	I-REL
deal	VB	I-REL
with	IN	O
pain	NN	O

HAVING	VBG	O
a	DT	O
good	JJ	O
giggle	NN	O
...	:	O
combats	VBZ	B-REL
pain	NN	O

A	DT	O
belly	NN	O
laugh	NN	O
triggers	VBZ	B-REL
the	DT	O
release	NN	O
of	IN	O
painkilling	NN	O
endorphins	NNS	O

Belly	NN	O
laughing	NN	O
for	IN	O
15	CD	O
minutes	NNS	O
releases	VBZ	B-REL
endorphins	NNS	I-REL
that	WDT	I-REL
increase	VBP	I-REL
our	PRP$	O
threshold	NN	O
to	TO	O
pain	NN	O

A	DT	O
rattling	VBG	O
good	JJ	O
laugh	NN	O
with	IN	O
friends	NNS	O
will	MD	B-REL
help	VB	I-REL
you	PRP	I-REL
deal	VB	I-REL
with	IN	O
pain	NN	O

15	CD	O
minutes	NNS	O
of	IN	O
comedy	NN	O
is	VBZ	O
enough	RB	O
to	TO	O
increase	VB	B-REL
the	DT	O
amount	NN	O
of	IN	O
pain	NN	O
people	NNS	O
can	MD	O
stand	VB	O

People	NNS	O
feel	VBP	B-REL
less	JJR	I-REL
pain	NN	I-REL
after	IN	I-REL
a	DT	I-REL
good	JJ	O
laugh	NN	O

vitamin	NN	O
A	NN	O
supplements	NNS	O
can	MD	B-REL
prevent	VB	I-REL
death	NN	O
and	CC	O
illness	NN	O

Vitamin	NN	O
A	NN	O
supplementation	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
large	JJ	O
reductions	NNS	O
in	IN	O
mortality	NN	O

giving	VBG	O
vitamin	NN	O
A	NN	O
supplements	NNS	O
to	TO	O
children	NNS	O
in	IN	O
low	JJ	O
and	CC	O
middle	JJ	O
income	NN	O
countries	NNS	O
could	MD	B-REL
significantly	RB	I-REL
cut	VB	I-REL
rates	NNS	O
of	IN	O
mortality	NN	O

Giving	VBG	O
vitamin	NN	O
A	NN	O
supplements	NNS	O
to	TO	O
children	NNS	O
under	IN	O
the	DT	O
age	NN	O
of	IN	O
five	CD	O
in	IN	O
developing	VBG	O
countries	NNS	O
could	MD	B-REL
save	VB	I-REL
600,000	CD	O
lives	VBZ	O
a	DT	O
year	NN	O

...	:	O
Semi-allogeneic	JJ	O
DC	NN	O
differentiated	VBN	O
from	IN	O
mouse	NN	O
ES	NN	O
cells	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	B-REL
to	TO	I-REL
stimulate	VB	I-REL
potent	JJ	O
antitumour	JJ	O
responses	NNS	O
in	IN	O
mice	NNS	O
,23	CD	O
indeed	RB	O
the	DT	O
stimulation	NN	O
of	IN	O
alloreactive	JJ	O
T	NN	O
cells	NNS	O
may	MD	O
provide	VB	O
a	DT	O
cytokine	NN	O
milieu	NN	O
conducive	JJ	O
to	TO	O
the	DT	O
priming	NN	O
of	IN	O
naive	JJ	O
T	NN	O
cells	NNS	O
specific	JJ	O
for	IN	O
TAA	NNP	O
...	:	O

...	:	O
iPS	NN	O
cells	NNS	O
offers	VBZ	O
the	DT	B-REL
possibility	NN	O
of	IN	B-REL
harnessing	VBG	O
their	PRP$	O
capacity	NN	O
for	IN	B-REL
cross-priming	NN	O
of	IN	O
cytotoxic	JJ	B-REL
T	NN	I-REL
lymphocytes	NNS	I-REL
for	IN	O
the	DT	O
induction	NN	B-REL
of	IN	O
tumour-specific	JJ	O
immune	JJ	O
responses	NNS	O
...	:	O

...	:	O
stem	NN	O
cell	NN	O
approach	NN	O
primes	VBZ	B-REL
immune	JJ	I-REL
system	NN	I-REL
to	TO	I-REL
fight	VB	I-REL
cancer	NN	O
...	:	O

...	:	O
Oxford	NNP	O
University	NNP	O
researchers	NNS	O
transformed	VBD	O
skin	NN	O
cells	NNS	O
into	IN	O
immune	JJ	O
cells	NNS	O
,	,	O
which	WDT	B-REL
could	MD	I-REL
be	VB	I-REL
used	VBN	I-REL
to	TO	I-REL
trigger	VB	I-REL
a	DT	I-REL
hunt	NN	I-REL
for	IN	O
cancer	NN	O
...	:	O

...	:	O
our	PRP$	O
findings	NNS	O
show	VBP	O
this	DT	O
switch	NN	O
co-evolved	VBD	B-REL
with	IN	I-REL
a	DT	I-REL
change	NN	I-REL
from	IN	O
a	DT	O
nocturnal	JJ	O
to	TO	O
a	DT	O
diurnal	JJ	O
lifestyle	NN	O
,	,	O
supporting	VBG	O
the	DT	O
role	NN	O
ofpredation	NN	O
in	IN	O
driving	VBG	O
social	JJ	O
evolution	NN	O
...	:	O

...	:	O
this	DT	O
structuring	NN	O
facilitates	VBZ	B-REL
the	DT	I-REL
evolution	NN	I-REL
of	IN	I-REL
cooperative	JJ	O
behaviours	NNS	O
...	:	O

...	:	O
origins	NNS	O
of	IN	O
human	JJ	O
social	JJ	O
networks	NNS	O
discovered	VBN	O
;	:	O
Humans	NNS	O
are	VBP	O
sociable	JJ	O
creatures	NNS	O
because	IN	O
our	PRP$	O
primate	JJ	O
ancestors	NNS	O
were	VBD	O
forced	VBN	B-REL
to	TO	I-REL
band	VB	I-REL
together	RB	I-REL
for	IN	I-REL
protection	NN	I-REL
when	WRB	O
they	PRP	O
stopped	VBD	O
being	VBG	O
nocturnal	JJ	O
...	:	O

...	:	O
our	PRP$	O
ancestors	NNS	O
gave	VBD	B-REL
up	RP	I-REL
their	PRP$	I-REL
solitary	JJ	I-REL
existence	NN	I-REL
when	WRB	I-REL
they	PRP	I-REL
shifted	VBD	I-REL
from	IN	I-REL
being	VBG	O
nocturnal	JJ	O
creatures	NNS	O
to	TO	O
those	DT	O
that	WDT	O
are	VBP	O
active	JJ	O
during	IN	O
the	DT	O
day	NN	O
...	:	O

...	:	O
this	DT	O
was	VBD	B-REL
linked	VBN	I-REL
to	TO	I-REL
a	DT	O
shift	NN	O
from	IN	O
nocturnal	JJ	O
to	TO	O
diurnal	JJ	O
living	NN	O
...	:	O

...	:	O
grapheme-color	NN	O
synesthetes	NNS	O
display	VBP	B-REL
enhanced	VBN	I-REL
cortical	JJ	I-REL
excitability	NN	I-REL
that	WDT	O
is	VBZ	O
specific	JJ	O
to	TO	O
primary	JJ	O
visual	JJ	O
cortex	NN	O
...	:	O

...	:	O
synesthetes	NNS	O
display	VBP	B-REL
3-fold	RB	I-REL
lower	JJR	I-REL
phosphene	NN	O
thresholds	NNS	O
than	IN	O
controls	NNS	O
...	:	O

...	:	O
hyper-excitability	NN	O
in	IN	O
regions	NNS	O
of	IN	O
the	DT	O
brain	NN	O
may	MD	B-REL
underlie	VB	I-REL
synaesthesia	NN	O
...	:	O

the	DT	O
advantageous	JJ	O
influence	NN	B-REL
of	IN	I-REL
context	NN	O
dependence	NN	O
in	IN	O
sequential	JJ	O
choices	NNS	O

adding	VBG	O
cues	NNS	O
that	WDT	O
identified	VBD	O
the	DT	O
context	NN	O
impaired	JJ	B-REL
performance	NN	O
in	IN	O
simultaneous	JJ	O
prey	NN	O
choices	NNS	O
but	CC	O
improved	VBD	O
it	PRP	O
in	IN	O
sequential	JJ	O
prey	NN	O
encounters	NNS	O

the	DT	O
birds	NNS	O
pay	VBP	O
too	RB	O
much	JJ	O
attention	NN	O
to	TO	B-REL
context	NN	O
:	:	O
this	DT	O
makes	VBZ	B-REL
them	PRP	I-REL
vulnerable	JJ	I-REL
to	TO	O
the	DT	O
sort	NN	O
of	IN	O
tricks	NNS	O
that	WDT	O
marketing	NN	O
specialists	NNS	O
use	VBP	O
to	TO	O
try	VB	O
to	TO	O
make	VB	O
human	JJ	O
shoppers	NNS	O
choose	VB	O
one	CD	O
product	NN	O
over	IN	O
another	DT	O

Other	JJ	O
areas	NNS	O
were	VBD	B-REL
significantly	RB	I-REL
activated	VBN	I-REL
by	IN	O
the	DT	O
assignment	NN	O
of	IN	O
authenticity	NN	O

viewing	NN	O
of	IN	O
artworks	NNS	O
assigned	VBN	O
as	IN	O
``	``	O
copy	NN	O
,	,	O
''	''	O
rather	RB	O
than	IN	O
``	``	O
authentic	JJ	O
,	,	O
''	''	O
evoked	VBD	B-REL
stronger	JJR	I-REL
responses	NNS	O
in	IN	O
frontopolar	JJ	O
cortex	NN	O
-LRB-	-LRB-	O
FPC	NN	O
-RRB-	-RRB-	O
,	,	O
and	CC	O
right	JJ	O
precuneus	NN	O

Being	VBG	O
told	VBD	O
that	IN	O
a	DT	O
work	NN	O
of	IN	O
art	NN	O
is	VBZ	O
authentic	JJ	O
or	CC	O
fake	JJ	O
alters	VBZ	B-REL
the	DT	O
brain	NN	O
's	POS	O
response	NN	O
to	TO	O
the	DT	O
visual	JJ	O
content	NN	O
of	IN	O
artwork	NN	O

the	DT	O
brain	NN	O
responds	VBZ	B-REL
differently	RB	I-REL
to	TO	I-REL
artwork	NN	I-REL
depending	VBG	I-REL
on	IN	I-REL
whether	IN	O
it	PRP	O
is	VBZ	O
said	VBN	O
to	TO	O
be	VB	O
authentic	JJ	O
,	,	O
or	CC	O
merely	RB	O
a	DT	O
good	JJ	O
imitation	NN	O

Behavioural	JJ	O
improvement	NN	O
evoked	VBN	B-REL
by	IN	O
tDCS	NN	O

Significant	JJ	O
behavioural	JJ	O
improvements	NNS	O
produced	VBN	B-REL
by	IN	O
anodal	JJ	O
stimulation	NN	O

Tiny	NNP	O
electric	JJ	O
currents	NNS	O
applied	VBD	O
across	IN	O
regions	NNS	O
of	IN	O
the	DT	O
brain	NN	O
can	MD	B-REL
improve	VB	I-REL
hand	NN	O
movements	NNS	O

adding	VBG	O
weight	NN	O
to	TO	B-REL
the	DT	I-REL
suggested	VBN	I-REL
link	NN	I-REL
between	IN	O
vitamin	NN	O
D	NN	O
and	CC	O
MS	NN	O

A	DT	O
rare	JJ	O
genetic	JJ	O
variant	NN	O
which	WDT	O
causes	VBZ	B-REL
reduced	VBN	O
levels	NNS	O
of	IN	O
vitamin	NN	O
D	NN	O

...	:	O
we	PRP	O
recorded	VBD	O
profound	JJ	O
abnormalities	NNS	B-REL
in	IN	I-REL
circadian	JJ	I-REL
sleep-wake	JJ	O
timing	NN	O
and	CC	O
in	IN	O
the	DT	O
rise	NN	O
and	CC	O
fall	NN	O
of	IN	O
melatonin	NN	O
levels	NNS	O
in	IN	O
people	NNS	O
with	IN	O
schizophrenia	NN	O
who	WP	O
have	VBP	O
long-standing	JJ	O
subjective	JJ	O
sleep	NN	O
problems	NNS	O
...	:	O

the	DT	O
resultant	JJ	O
population	NN	O
delayed	VBN	B-REL
skin	NN	O
allograft	NN	O
rejection	NN	O

A	DT	O
cell	NN	O
therapy	NN	O
that	WDT	O
could	MD	B-REL
prevent	VB	I-REL
transplanted	VBN	O
organs	NNS	O
being	VBG	O
rejected	VBN	O
,	,	O
and	CC	O
remove	VB	O
the	DT	O
need	NN	O
for	IN	O
prolonged	JJ	O
use	NN	O
of	IN	O
immunosuppressant	JJ	O
drugs	NNS	O
,	,	O
has	VBZ	O
shown	VBN	O
promise	NN	O
in	IN	O
early-stage	JJ	O
studies	NNS	O
in	IN	O
mice	NNS	O

dementia	NN	O
has	VBZ	B-REL
a	DT	I-REL
very	RB	I-REL
significant	JJ	I-REL
impact	NN	I-REL
across	IN	O
the	DT	O
EU-15	NN	O
,	,	O
mostly	RB	O
due	JJ	O
to	TO	O
the	DT	O
burden	NN	O
on	IN	O
unpaid	JJ	O
carers	NNS	O
and	CC	O
long-term	JJ	O
institutionalised	JJ	O
care	NN	O

Dementia	NN	O
poses	VBZ	B-REL
a	DT	O
significant	JJ	O
economic	JJ	O
burden	NN	O
to	TO	O
European	JJ	O
health	NN	O
and	CC	O
social	JJ	O
care	NN	O
systems	NNS	O
,	,	O
and	CC	O
society	NN	O
overall	JJ	O

Dementia	NN	O
costs	NNS	B-REL
Europe	NNP	O
PS165	CD	O
billion	CD	O
a	DT	O
year	NN	O

THE	DT	O
cost	NN	O
of	IN	O
Alzheimer	NN	O
's	POS	O
disease	NN	O
and	CC	O
dementia	NN	O
has	VBZ	B-REL
risen	VBN	I-REL
to	TO	O
PS34billion	NN	O
a	DT	O
year	NN	O

ROS	NN	O
derived	VBN	O
specifically	RB	O
from	IN	O
Nox2	JJ	O
NADPH	NN	O
oxidase	NN	O
make	VBP	B-REL
a	DT	I-REL
significant	JJ	I-REL
contribution	NN	I-REL
to	TO	O
several	JJ	O
key	JJ	O
processes	NNS	O
underlying	VBG	O
cardiac	JJ	O
remodeling	NN	O
associated	VBN	O
with	IN	O
doxorubicin	NN	O
chemotherapy	NN	O

ROS	NN	O
specifically	RB	O
derived	VBN	O
from	IN	O
Nox2	JJ	O
NADPH	NN	O
oxidase	NN	O
make	VBP	B-REL
a	DT	I-REL
substantial	JJ	I-REL
contribution	NN	I-REL
to	TO	O
several	JJ	O
key	JJ	O
processes	NNS	O
underlying	VBG	O
development	NN	O
of	IN	O
cardiac	JJ	O
contractile	NN	O
dysfunction	NN	O
and	CC	O
remodeling	NN	O
associated	VBN	O
with	IN	O
doxorubicin	NN	O
chemotherapy	NN	O

Scientists	NNS	O
at	IN	O
Queen	NNP	O
's	POS	O
Centre	NNP	O
for	IN	O
Vision	NNP	O
and	CC	O
Vascular	JJ	O
Science	NN	O
have	VBP	O
discovered	VBN	O
the	DT	O
role	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
which	WDT	O
,	,	O
when	WRB	O
a	DT	O
patient	NN	O
receives	VBZ	O
chemotherapy	NN	O
,	,	O
can	MD	B-REL
cause	VB	I-REL
life-threatening	JJ	O
damage	NN	O
to	TO	O
the	DT	O
heart	NN	O

Scientists	NNS	O
have	VBP	O
identified	VBN	O
the	DT	O
role	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
that	WDT	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
heart	NN	O
failure	NN	O
among	IN	O
patients	NNS	O
who	WP	O
are	VBP	O
receiving	VBG	O
drugs	NNS	O
to	TO	O
kill	VB	O
tumours	NNS	O

our	PRP$	O
results	NNS	O
emphasize	VBP	O
the	DT	O
energetic	JJ	O
costs	NNS	O
of	IN	O
brain	NN	O
development	NN	O
as	IN	O
a	DT	O
driver	NN	O
of	IN	O
associations	NNS	B-REL
between	IN	I-REL
brain	NN	O
size	NN	O
and	CC	O
life	NN	O
history	NN	O
in	IN	O
mammals	NNS	O

evolutionary	JJ	O
changes	NNS	O
in	IN	O
pre	JJ	O
-	:	O
and	CC	O
postnatal	JJ	O
brain	NN	O
growth	NN	O
correlate	VBP	B-REL
specifically	RB	I-REL
with	IN	O
duration	NN	O
of	IN	O
the	DT	O
relevant	JJ	O
phases	NNS	O
of	IN	O
maternal	JJ	O
investment	NN	O
-LRB-	-LRB-	O
gestation	NN	O
and	CC	O
lactation	NN	O
,	,	O
respectively	RB	O
-RRB-	-RRB-	O

brain	NN	O
growth	NN	O
in	IN	O
babies	NNS	O
is	VBZ	B-REL
determined	VBN	I-REL
by	IN	I-REL
the	DT	O
duration	NN	O
of	IN	O
pregnancy	NN	O
and	CC	O
how	WRB	O
long	RB	O
they	PRP	O
suckle	VBP	O

there	EX	O
is	VBZ	B-REL
a	DT	I-REL
direct	JJ	I-REL
correlation	NN	I-REL
between	IN	I-REL
the	DT	O
size	NN	O
of	IN	O
a	DT	O
mammal	NN	O
's	POS	O
brain	NN	O
and	CC	O
the	DT	O
amount	NN	O
of	IN	O
time	NN	O
they	PRP	O
suckle	VBP	O

this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
description	NN	O
of	IN	O
a	DT	B-REL
role	NN	I-REL
for	IN	I-REL
FKBPL	NN	I-REL
as	IN	I-REL
an	DT	I-REL
antiangiogenic	JJ	I-REL
protein	NN	I-REL

FKBPL	NN	O
and	CC	O
its	PRP$	O
peptide	NN	O
derivative	JJ	O
AD-01	NN	O
have	VBP	B-REL
potent	JJ	I-REL
antiangiogenic	JJ	I-REL
activity	NN	I-REL

new	JJ	O
treatment	NN	O
for	IN	O
cancer	NN	O
which	WDT	O
rather	RB	O
than	IN	O
attacking	VBG	O
tumours	NNS	O
directly	RB	O
,	,	O
prevents	VBZ	O
the	DT	O
growth	NN	O
of	IN	O
new	JJ	O
blood	NN	O
vessels	NNS	O
in	IN	O
tumours	NNS	O
,	,	O
starving	VBG	O
them	PRP	O
of	IN	O
oxygen	NN	O
and	CC	O
nutrients	NNS	O
,	,	O
thereby	RB	O
preventing	VBG	B-REL
their	PRP$	O
growth	NN	O

The	DT	O
treatment	NN	O
attacks	NNS	B-REL
blood	NN	O
vessels	NNS	O
in	IN	O
tumours	NNS	O
by	IN	O
starving	VBG	O
them	PRP	O
of	IN	O
oxygen	NN	O
and	CC	O
nutrients	NNS	O

administration	NN	O
of	IN	O
ivacaftor	NN	O
,	,	O
an	DT	O
oral	JJ	O
CFTR	NN	O
potentiator	NN	O
,	,	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
significant	JJ	O
improvements	NNS	O
in	IN	O
primary	JJ	O
and	CC	O
secondary	JJ	O
end	NN	O
points	NNS	O
in	IN	O
persons	NNS	O
with	IN	O
cystic	JJ	O
fibrosis	NN	O
who	WP	O
had	VBD	O
at	IN	O
least	JJS	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
G551D-CFTR	NN	O
mutation	NN	O

Ivacaftor	NNP	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
improvements	NNS	O
in	IN	O
lung	NN	O
function	NN	O
at	IN	O
2	CD	O
weeks	NNS	O
that	WDT	O
were	VBD	O
sustained	VBN	O
through	IN	O
48	CD	O
weeks	NNS	O

Trials	NNS	O
of	IN	O
VX-770	NN	O
at	IN	O
Queen	NNP	O
's	POS	O
University	NNP	O
in	IN	O
Belfast	NNP	O
were	VBD	O
found	VBN	O
to	TO	O
significantly	RB	B-REL
improve	VB	I-REL
lung	NN	O
function	NN	O
and	CC	O
quality	NN	O
of	IN	O
life	NN	O
for	IN	O
sufferers	NNS	O

A	DT	O
NEW	JJ	O
drug	NN	O
which	WDT	O
makes	VBZ	B-REL
it	PRP	O
easier	JJR	O
to	TO	O
clear	VB	O
the	DT	O
lungs	NNS	O
of	IN	O
bacteria	NNS	O

the	DT	O
combination	NN	O
of	IN	O
docetaxel	NN	O
with	IN	O
the	DT	O
bone-seeking	JJ	O
radiopharmaceutical	JJ	O
186Re-HEDP	NN	O
can	MD	B-REL
be	VB	I-REL
safely	RB	I-REL
used	VBN	I-REL

aspirin	NN	O
reduced	VBD	B-REL
incidence	NN	O
of	IN	O
colorectal	JJ	O
cancer	NN	O
with	IN	O
the	DT	O
eff	NN	O
ect	NN	O
becoming	VBG	O
apparent	JJ	O
after	IN	O
3-4	CD	O
years	NNS	O
from	IN	O
the	DT	O
start	NN	O
of	IN	O
aspirin	NN	O
intervention	NN	O

600	CD	O
mg	NN	O
aspirin	NN	O
per	IN	O
day	NN	O
for	IN	O
a	DT	O
mean	NN	O
of	IN	O
25	CD	O
months	NNS	O
substantially	RB	B-REL
reduced	VBD	I-REL
cancer	NN	O
incidence	NN	O
after	IN	O
55	CD	O
*	SYM	O
7	CD	O
months	NNS	O

taking	VBG	O
regular	JJ	O
aspirin	NN	O
halves	VBZ	B-REL
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
hereditary	JJ	O
cancers	NNS	O

TAKING	VBG	O
aspirin	NN	O
regularly	RB	O
can	MD	B-REL
cut	VB	I-REL
the	DT	O
long-term	JJ	O
risk	NN	O
of	IN	O
cancer	NN	O

The	DT	O
dose	NN	O
cut	VBD	B-REL
the	DT	O
risk	NN	O
of	IN	O
bowel	NN	O
cancer	NN	O

TWO	CD	O
ASPIRIN	NN	O
A	DT	O
DAY	NN	O
PREVENTS	VBZ	B-REL
CANCER	NNP	O

taking	VBG	O
two	CD	O
of	IN	O
the	DT	O
``	``	O
wonder	NN	O
''	''	O
pills	NNS	O
a	DT	O
day	NN	O
gives	VBZ	B-REL
long-term	JJ	O
protection	NN	O

Aspirin	NN	O
cuts	VBZ	B-REL
the	DT	O
chances	NNS	O
of	IN	O
developing	VBG	O
bowel	NN	O
cancer	NN	O

regularly	RB	O
taking	VBG	O
the	DT	O
medicine	NN	O
cuts	VBZ	B-REL
the	DT	O
risk	NN	O
of	IN	O
bowel	NN	O
cancer	NN	O

Aspirin	NN	O
cuts	NNS	B-REL
bowel	NN	O
cancer	NN	O
risk	NN	O

Two	CD	O
pills	NNS	O
a	DT	O
day	NN	O
for	IN	O
two	CD	O
years	NNS	O
reduced	VBD	B-REL
the	DT	O
incidence	NN	O
of	IN	O
bowel	NN	O
cancer	NN	O

Taking	VBG	O
two	CD	O
aspirin	NN	O
a	DT	O
day	NN	O
for	IN	O
two	CD	O
years	NNS	O
reduces	VBZ	B-REL
the	DT	O
long-term	JJ	O
risk	NN	O
of	IN	O
bowel	NN	O
cancer	NN	O

Aspirin	NN	O
cuts	NNS	B-REL
hereditary	JJ	O
cancer	NN	O
risK	NN	O

miR-96	NN	O
is	VBZ	O
a	DT	O
late	JJ	O
embryonic/early	JJ	O
postnatal	JJ	O
upstream	JJ	O
regulator	NN	O
of	IN	O
mRNA	NN	O
translation	NN	O
that	WDT	O
ensures	VBZ	B-REL
controlled	JJ	O
and	CC	O
highly	RB	O
coordinated	VBN	O
differential	JJ	O
development	NN	O
of	IN	O
mammalian	JJ	O
cochlear	JJ	O
IHCs	NNS	O
and	CC	O
OHCs	NNS	O

miR-96	NN	O
regulates	VBZ	B-REL
the	DT	O
progression	NN	O
of	IN	O
the	DT	O
physiological	JJ	O
and	CC	O
morphological	JJ	O
differentiation	NN	O
of	IN	O
cochlear	JJ	O
hair	NN	O
cells	NNS	O

deafness	NN	O
is	VBZ	B-REL
caused	VBN	I-REL
by	IN	I-REL
a	DT	O
mutation	NN	O
of	IN	O
a	DT	O
specific	JJ	O
microRNA	NN	O
called	VBN	O
miR-96	NN	O

between	IN	O
the	DT	O
ages	NNS	O
of	IN	O
15	CD	O
and	CC	O
18	CD	O
months	NNS	O
,	,	O
infants	NNS	O
begin	VBP	B-REL
to	TO	I-REL
learn	VB	I-REL
the	DT	O
abstract	JJ	O
principles	NNS	O
governing	VBG	O
correct	JJ	O
counting	NN	O
via	IN	O
exposure	NN	O
to	TO	O
their	PRP$	O
cultural	JJ	O
counting	NN	O
routine	NN	O

infants	NNS	O
start	VBP	B-REL
to	TO	I-REL
acquire	VB	I-REL
the	DT	O
abstract	JJ	O
principles	NNS	O
governing	VBG	O
correct	JJ	O
counting	NN	O
prior	RB	O
to	TO	O
producing	VBG	O
any	DT	O
counting	VBG	O
behaviour	NN	O

Toddlers	NNPS	O
recognise	VBP	B-REL
basic	JJ	O
arithmetic	NN	O
by	IN	O
the	DT	O
time	NN	O
they	PRP	O
are	VBP	O
18-months-old	JJ	O

Infants	NNS	O
can	MD	B-REL
count	VB	I-REL
from	IN	O
18	CD	O
months	NNS	O
of	IN	O
age	NN	O

...	:	O
mice	NNS	O
bearing	VBG	O
both	CC	O
subcutaneous	JJ	O
and	CC	O
orthotopic	JJ	O
tumors	NNS	O
exhibited	VBD	O
remarkable	JJ	O
tumor	NN	B-REL
regression	NN	I-REL
following	VBG	I-REL
a	DT	O
single	JJ	O
injection	NN	O
of	IN	O
cotransduced	JJ	O
MDMs	NNS	O
...	:	O

The	DT	O
virus	NN	O
then	RB	O
infected	JJ	O
neighboring	JJ	O
cells	NNS	O
but	CC	O
only	RB	O
proliferated	VBD	O
and	CC	O
was	VBD	O
cytotoxic	JJ	O
in	IN	B-REL
prostate	NN	O
tumor	NN	O
cells	NNS	O
,	,	O
resulting	VBG	B-REL
in	IN	O
the	DT	O
marked	JJ	O
inhibition	NN	O
of	IN	O
tumor	NN	O
growth	NN	O
and	CC	O
reduction	NN	O
of	IN	O
pulmonary	JJ	O
metastases	NNS	O

New	JJ	O
treatment	NN	O
can	MD	B-REL
destroy	VB	I-REL
prostate	NN	O
cancer	NN	O
from	IN	O
within	IN	O

despite	IN	O
a	DT	O
substantial	JJ	O
decrease	NN	O
in	IN	O
prescribing	VBG	O
of	IN	O
antibiotic	JJ	O
prophylaxis	NN	O
in	IN	O
England	NNP	O
since	IN	O
the	DT	O
introduction	NN	O
of	IN	O
NICE	JJ	O
guideline	NN	O
No	DT	O
64	CD	O
in	IN	O
March	NNP	O
2008	CD	O
there	EX	B-REL
has	VBZ	I-REL
been	VBN	I-REL
no	DT	I-REL
significant	JJ	I-REL
increase	NN	I-REL
in	IN	O
the	DT	O
number	NN	O
of	IN	O
cases	NNS	O
of	IN	O
infective	JJ	O
endocarditis	NN	O

this	DT	O
study	NN	O
excluded	VBN	B-REL
any	DT	I-REL
large	JJ	I-REL
increase	NN	I-REL
in	IN	O
the	DT	O
incidence	NN	O
of	IN	O
cases	NNS	O
of	IN	O
or	CC	O
deaths	NNS	O
from	IN	O
infective	JJ	O
endocarditis	NN	O

a	DT	O
common	JJ	O
treatment	NN	O
for	IN	O
a	DT	O
life-threatening	JJ	O
heart	NN	O
condition	NN	O
has	VBZ	B-REL
little	JJ	I-REL
significant	JJ	I-REL
impact	NN	I-REL
on	IN	I-REL
patient	NN	O
outcomes	NNS	O

many	JJ	O
of	IN	O
the	DT	O
respondents	NNS	O
used	VBD	O
music	NN	O
listening	VBG	O
to	TO	B-REL
improve	VB	I-REL
their	PRP$	O
well-being	NN	O
in	IN	O
the	DT	O
workplace	NN	O
.	.	O

Listening	VBG	O
to	TO	O
music	NN	O
at	IN	O
work	NN	O
can	MD	B-REL
help	VB	I-REL
office	NN	O
workers	NNS	O
relax	VBP	O
,	,	O
improve	VBP	O
their	PRP$	O
mood	NN	O
and	CC	O
make	VB	O
them	PRP	O
feel	VB	O
happier	JJR	O

...	:	O
the	DT	O
retina	NN	O
of	IN	O
adults	NNS	O
who	WP	O
are	VBP	O
either	CC	O
born	VBN	O
deaf	JJ	O
or	CC	O
have	VBP	O
an	DT	O
onset	NN	O
of	IN	O
deafness	NN	O
...	:	O
develops	VBZ	B-REL
differently	RB	I-REL
to	TO	I-REL
hearing	VBG	O
adults	NNS	O
...	:	O

...	:	O
the	DT	O
retinas	NN	O
of	IN	O
people	NNS	O
born	VBN	O
deaf	JJ	O
,	,	O
or	CC	O
who	WP	O
lost	VBD	O
their	PRP$	O
hearing	NN	O
early	RB	O
in	IN	O
life	NN	O
,	,	O
developed	VBD	B-REL
differently	RB	I-REL
from	IN	I-REL
those	DT	O
in	IN	O
people	NNS	O
who	WP	O
can	MD	O
hear	VB	O
...	:	O

...	:	O
People	NNS	O
who	WP	O
are	VBP	O
deaf	JJ	O
have	VBP	O
better	JJR	O
sight	NN	O
because	IN	O
their	PRP$	O
retinas	NN	O
develop	VB	B-REL
more	JJR	I-REL
fully	RB	I-REL
to	TO	O
allow	VB	O
greater	JJR	O
peripheral	JJ	O
vision	NN	O
and	CC	O
capture	VB	O
more	JJR	O
information	NN	O
...	:	O

...	:	O
PEOPLE	NNP	O
who	WP	O
are	VBP	O
deaf	JJ	O
from	IN	O
birth	NN	O
develop	VBP	O
enhanced	VBN	O
sight	NN	O
because	IN	O
of	IN	B-REL
changes	NNS	I-REL
to	TO	O
their	PRP$	O
retinas	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
interventional	JJ	O
study	NN	O
demonstrating	VBG	O
an	DT	O
atherogenic	JJ	O
effect	NN	B-REL
of	IN	O
dietary	JJ	O
phosphate	NN	O
supplementation	NN	O

A	DT	O
high-phosphate	JJ	O
diet	NN	O
accelerates	VBZ	B-REL
atherogenesis	NN	O
in	IN	O
apolipoprotein	NN	O
E	NN	O
/	:	O
mice	NNS	O

Lowering	VBG	O
phosphate	NN	O
intake	NN	O
in	IN	O
humans	NNS	O
can	MD	B-REL
reduce	VB	I-REL
heart	NN	O
disease	NN	O

LOWERING	VBG	O
your	PRP$	O
intake	NN	O
of	IN	O
phosphates	NNS	O
-LRB-	-LRB-	O
a	DT	O
common	JJ	O
food	NN	O
additive	JJ	O
-RRB-	-RRB-	O
can	MD	B-REL
reduce	VB	I-REL
the	DT	O
risk	NN	O
of	IN	O
heart	NN	O
disease	NN	O

...	:	O
the	DT	B-REL
introduction	NN	O
of	IN	O
a	DT	O
4-hour	JJ	O
target	NN	O
for	IN	O
ED	NN	O
patients	NNS	O
has	VBZ	B-REL
led	VBN	I-REL
to	TO	I-REL
improvements	NNS	I-REL
in	IN	I-REL
the	DT	O
proportion	NN	O
of	IN	O
patients	NNS	O
managed	VBD	O
within	IN	O
this	DT	O
timeframe	NN	O
...	:	O

...	:	O
the	DT	B-REL
introduction	NN	O
of	IN	B-REL
a	DT	O
time	NN	O
target	NN	O
reduced	VBD	B-REL
the	DT	O
proportion	NN	B-REL
of	IN	O
patients	NNS	B-REL
staying	VBG	I-REL
greater	JJR	O
than	IN	O
4	CD	O
hours	NNS	O
...	:	O

...	:	O
emergency	NN	O
department	NN	O
target	NN	O
may	MD	B-REL
not	RB	I-REL
have	VB	I-REL
improved	VBN	I-REL
patient	NN	O
care	NN	O
...	:	O

In	IN	O
both	DT	O
swarms	NNS	O
,	,	O
the	DT	O
pink	NN	O
and	CC	O
yellow	JJ	O
dancers	NNS	O
both	CC	O
received	VBD	O
many	JJ	B-REL
more	JJR	I-REL
signals	NNS	I-REL
from	IN	O
different-colored	JJ	O
bees	NNS	O
than	IN	O
from	IN	O
same-colored	JJ	O
bees	NNS	O

Nest-site	JJ	O
scouts	NNS	O
send	VBP	O
inhibitory	JJ	O
stop	NN	O
signals	NNS	O
to	TO	O
other	JJ	O
scouts	NNS	O
producing	VBG	O
waggle	NN	O
dances	NNS	O
,	,	O
causing	VBG	B-REL
them	PRP	O
to	TO	O
cease	VB	O
dancing	NN	O
,	,	O
and	CC	O
each	DT	O
scout	NN	O
targets	VBZ	O
scouts	NNS	O
'	POS	O
reporting	VBG	O
sites	NNS	O
other	JJ	O
than	IN	O
her	PRP$	O
own	JJ	O

The	DT	O
unique	JJ	O
system	NN	O
allows	VBZ	B-REL
them	PRP	O
to	TO	O
solve	VB	O
disputes	NNS	O
and	CC	O
banish	VB	O
indecision	NN	O

The	DT	O
presence	NN	O
of	IN	O
fine	JJ	O
body	NN	O
hair	NN	O
enhances	VBZ	B-REL
the	DT	O
detection	NN	O
of	IN	O
searching	VBG	O
ectoparasites	NNS	O

Fine	JJ	O
body	NN	O
hair	NN	O
enhances	VBZ	B-REL
the	DT	O
detection	NN	O
of	IN	O
ectoparasites	NNS	O

Sensitive	JJ	O
,	,	O
fine	JJ	O
hairs	NNS	O
which	WDT	O
cover	VBP	O
our	PRP$	O
bodies	NNS	O
allow	VBP	O
us	PRP	O
to	TO	B-REL
feel	VB	O
parasitic	JJ	O
insect	NN	O
on	IN	O
our	PRP$	O
skin	NN	O
as	RB	O
well	RB	O
as	IN	O
creating	VBG	O
a	DT	O
natural	JJ	O
barrier	NN	O
to	TO	O
stop	VB	B-REL
them	PRP	O
biting	VBG	O
us	PRP	O

A	DT	O
hair	NN	O
body	NN	O
can	MD	B-REL
mean	VB	I-REL
the	DT	O
bed	NN	O
bugs	NNS	O
wo	MD	O
n't	RB	O
bite	VB	O

Body	NN	O
hair	NN	O
protects	VBZ	B-REL
us	PRP	I-REL
from	IN	I-REL
bed	NN	O
bugs	NNS	O

Hairy	JJ	O
arms	NNS	O
stop	VBP	B-REL
bedbug	NN	O
bites	VBZ	O

Sensitive	JJ	O
hairs	NNS	O
helps	VBZ	B-REL
us	PRP	I-REL
feel	VB	O
small	JJ	O
insects	NNS	O
on	IN	O
our	PRP$	O
skin	NN	O
,	,	O
and	CC	O
act	VBP	O
as	IN	O
a	DT	O
barrier	NN	O
that	WDT	O
stops	VBZ	O
them	PRP	O
from	IN	O
sinking	VBG	O
their	PRP$	O
teeth	NNS	O
in	IN	O

Hairier	JJR	O
skin	NN	O
may	MD	B-REL
be	VB	I-REL
the	DT	I-REL
key	NN	I-REL
to	TO	O
avoiding	VBG	O
being	VBG	O
bitten	VBN	O
by	IN	O
bed	NN	O
bugs	NNS	O

early	RB	O
development	NN	O
of	IN	O
the	DT	O
fetus	NN	O
influences	VBZ	B-REL
the	DT	O
lateralization	NN	O
of	IN	O
cerebral	JJ	O
activity	NN	O

lateralization	NN	O
of	IN	O
cerebral	JJ	O
activity	NN	O
is	VBZ	O
influenced	VBN	B-REL
persistently	RB	O
by	IN	O
early	JJ	O
developmental	JJ	O
experiences	NNS	O

linking	VBG	B-REL
brain	NN	O
function	NN	O
variations	NNS	O
between	IN	O
the	DT	O
left	JJ	O
and	CC	O
right	JJ	O
sides	NNS	O
of	IN	O
the	DT	O
brain	NN	O
to	TO	O
size	NN	O
at	IN	O
birth	NN	O
and	CC	O
the	DT	O
weight	NN	O
of	IN	O
the	DT	O
placenta	NN	O

both	DT	O
forms	NNS	O
of	IN	O
conduct	NN	O
disorder	NN	O
may	MD	B-REL
stem	VB	I-REL
from	IN	O
dysfunction	NN	O
in	IN	O
neural	JJ	O
circuits	NNS	O
involved	VBN	O
in	IN	O
emotion	NN	O
processing	NN	O

Brain	NN	O
structural	JJ	O
abnormalities	NNS	O
may	MD	B-REL
contribute	VB	I-REL
to	TO	I-REL
the	DT	O
emergence	NN	O
of	IN	O
adolescent	JJ	O
-	:	O
onset	NN	O
as	RB	O
well	RB	O
as	IN	O
early-onset	JJ	O
conduct	NN	O
disorder	NN	O

Brain	NN	O
scans	NNS	O
of	IN	O
aggressive	JJ	O
and	CC	O
antisocial	JJ	O
teenage	JJ	O
boys	NNS	O
with	IN	O
conduct	NN	O
disorder	NN	O
-LRB-	-LRB-	O
CD	NN	O
-RRB-	-RRB-	O
have	VBP	O
revealed	VBN	O
differences	NNS	B-REL
in	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
developing	VBG	O
brain	NN	O

Bad	JJ	O
behaviour	NN	O
in	IN	O
teenagers	NNS	O
could	MD	B-REL
be	VB	I-REL
explained	VBN	I-REL
by	IN	I-REL
stunted	VBN	O
growth	NN	O
of	IN	O
the	DT	O
``	``	O
caring-sharing	NN	O
''	''	O
areas	NNS	O
of	IN	O
their	PRP$	O
brains	NNS	O

Brain	NN	O
scans	NNS	O
of	IN	O
aggressive	JJ	O
,	,	O
antisocial	JJ	O
teenage	JJ	O
boys	NNS	O
with	IN	O
the	DT	O
condition	NN	O
known	VBN	O
as	IN	O
conduct	NN	O
disorder	NN	O
have	VBP	O
found	VBN	O
differences	NNS	O
in	IN	O
the	DT	O
size	NN	O
and	CC	O
structure	NN	O
of	IN	O
parts	NNS	O
of	IN	O
the	DT	O
brain	NN	O
that	WDT	O
may	MD	B-REL
be	VB	I-REL
linked	VBN	I-REL
to	TO	I-REL
their	PRP$	O
behavior	NN	O

the	DT	B-REL
association	NN	I-REL
between	IN	I-REL
RXRA	NN	O
chr9	NN	O
:136355885	CD	O
+	CC	O
methylation	NN	O
and	CC	O
mother	NN	O
's	POS	O
carbohydrate	NN	O
intake	NN	O

Higher	JJR	O
methylation	NN	O
of	IN	O
RXRA	NN	O
chr9	NN	O
:136355885	CD	O
+	CC	O
...	:	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
lower	JJR	O
maternal	JJ	O
carbohydrate	NN	O
intake	NN	O

During	IN	O
pregnancy	NN	O
,	,	O
a	DT	O
mother	NN	O
's	POS	O
diet	NN	O
can	MD	B-REL
alter	VB	O
the	DT	O
function	NN	O
of	IN	O
her	PRP$	O
child	NN	O
's	POS	O
DNA	NN	O

Mother	NNP	O
's	POS	O
diet	NN	O
during	IN	O
pregnancy	NN	O
alters	VBZ	B-REL
baby	NN	O
's	POS	O
DNA	NN	O

bronchoconstriction	NN	O
induces	VBZ	B-REL
epithelial	JJ	O
stress	NN	O
and	CC	O
initiates	VBZ	O
a	DT	O
tissue	NN	O
response	NN	O
that	WDT	O
leads	VBZ	O
to	TO	O
structural	JJ	O
airway	NN	O
changes	NNS	O

Bronchoconstriction	NN	O
without	IN	O
additional	JJ	O
inflammation	NN	O
induces	VBZ	B-REL
airway	NN	O
remodeling	NN	O
in	IN	O
patients	NNS	O
with	IN	O
asthma	NN	O

that	IN	O
the	DT	O
progressive	JJ	O
loss	NN	O
of	IN	B-REL
lung	NN	O
function	NN	O
in	IN	O
asthma	NN	O
sufferers	NNS	O
could	MD	B-REL
be	VB	I-REL
entirely	RB	I-REL
independent	JJ	I-REL
of	IN	O
the	DT	O
effects	NNS	O
of	IN	O
inflammation	NN	O

a	DT	O
mechanism	NN	O
of	IN	O
tumor	NN	O
resistance	NN	O
by	IN	O
which	WDT	O
FcgRIIb	NN	O
on	IN	O
the	DT	O
primary	JJ	O
B	NN	O
cells	NNS	O
promotes	VBZ	B-REL
internalisation	NN	O

Target-cell	JJ	O
FcgRIIb	NN	O
promoted	VBD	B-REL
rituximab	JJ	O
internalisation	NN	O

The	DT	O
findings	NNS	O
of	IN	O
this	DT	O
study	NN	O
suggest	VBP	O
that	IN	O
mide-life	NN	O
is	VBZ	O
an	DT	O
increasingly	RB	B-REL
heterogeneous	JJ	O
life	NN	O
course	NN	O
stage	NN	O

The	DT	O
characteristics	NNS	O
of	IN	O
mid-life	NN	O
have	VBP	O
seen	VBN	B-REL
big	JJ	I-REL
changes	NNS	I-REL
over	IN	O
recent	JJ	O
decades	NNS	O

Overall	JJ	O
quality	NN	O
of	IN	O
life	NN	O
of	IN	O
women	NNS	O
with	IN	O
metastatic	JJ	O
breast	NN	O
cancer	NN	O
is	VBZ	O
poor	JJ	B-REL

This	DT	O
group	NN	O
reports	VBZ	O
high	JJ	B-REL
symptom	NN	O
burden	NN	O

235	CD	O
women	NNS	O
surveyed	VBN	O
27	CD	O
per	IN	O
cent	NN	O
had	VBD	B-REL
shortness	NN	O
of	IN	O
breath	NN	O

Some	DT	O
34	CD	O
%	NN	O
lived	VBD	O
with	IN	O
high	JJ	B-REL
pain	NN	O
levels	NNS	O

bisphosphonate	NN	O
use	NN	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
significantly	RB	O
lower	JJR	O
rate	NN	O
of	IN	O
revision	NN	O
surgery	NN	O
of	IN	O
up	RB	O
to	TO	O
about	IN	O
50	CD	O
%	NN	O
and	CC	O
a	DT	O
twofold	RB	O
greater	JJR	O
median	NN	O
implant	VB	O
survival	NN	O
time	NN	O
after	IN	O
primary	JJ	O
total	JJ	O
arthroplasty	NN	O
of	IN	O
the	DT	O
lower	JJR	O
limb	NN	O
in	IN	O
patients	NNS	O
without	IN	O
a	DT	O
previous	JJ	O
fracture	NN	O

bisphosphonate	NN	O
use	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
an	DT	O
almost	RB	O
twofold	JJ	O
increase	NN	O
in	IN	O
implant	VB	O
survival	NN	O
time	NN	O

Patients	NNS	O
who	WP	O
have	VBP	O
undergone	VBN	O
knee	NN	O
or	CC	O
hip	NN	O
replacement	NN	O
surgery	NN	O
could	MD	B-REL
potentially	RB	I-REL
double	VB	I-REL
the	DT	O
life	NN	O
of	IN	O
their	PRP$	O
implant	VB	O
by	IN	O
taking	VBG	O
readily	RB	O
available	JJ	O
osteoporosis	NN	O
drugs	NNS	O
called	VBN	O
bisphosphonates	NNS	O

Bisphosphonates	NNP	O
`	``	O
extend	VB	B-REL
hip	NN	O
replacement	NN	O
life	NN	O
'	''	O

mammographic	JJ	O
breast	NN	O
cancer	NN	O
screening	NN	O
could	MD	B-REL
be	VB	I-REL
causing	VBG	I-REL
more	JJR	O
harm	NN	O
than	IN	O
good	JJ	O

the	DT	O
introduction	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
screening	NN	O
might	MD	B-REL
have	VB	I-REL
caused	VBN	I-REL
net	JJ	O
harm	NN	O

the	DT	O
introduction	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
screening	NN	O
in	IN	O
the	DT	O
UK	NNP	O
may	MD	B-REL
have	VB	I-REL
caused	VBN	I-REL
more	RBR	O
harm	NN	O
than	IN	O
good	JJ	O

BREAST	NN	O
cancer	NN	O
screening	NN	O
may	MD	B-REL
cause	VB	I-REL
more	JJR	O
harm	NN	O
than	IN	O
good	JJ	O

breast	NN	O
cancer	NN	O
screening	NN	O
...	:	O
does	VBZ	B-REL
women	NNS	O
more	RBR	O
harm	NN	O
than	IN	O
good	JJ	O

Screening	VBG	O
programmes	NNS	O
...	:	O
lead	VB	B-REL
to	TO	I-REL
misdiagnosed	JJ	O
results	NNS	O
and	CC	O
the	DT	O
overtreatment	NN	O
of	IN	O
harmless	JJ	O
lumps	NNS	O

...	:	O
we	PRP	O
showed	VBD	O
that	IN	O
nostalgia	NN	O
increased	VBD	B-REL
charitable	JJ	O
intentions	NNS	O
...	:	O

...	:	O
by	IN	O
virtue	NN	O
of	IN	O
its	PRP$	O
capacity	NN	O
to	TO	O
increase	VB	B-REL
empathy	NN	O
,	,	O
nostalgia	NN	O
facilitates	VBZ	O
prosocial	JJ	O
reactions	NNS	O
...	:	O

...	:	O
charities	NNS	O
and	CC	O
not	RB	O
for	IN	O
profit	NN	O
organisations	NNS	O
can	MD	O
benefit	VB	O
from	IN	O
people	NNS	O
's	POS	O
nostalgic	JJ	O
feelings	NNS	O
,	,	O
because	IN	B-REL
it	PRP	I-REL
encourages	VBZ	I-REL
them	PRP	I-REL
to	TO	I-REL
donate	VB	O
more	JJR	O
...	:	O

No	DT	B-REL
detectable	JJ	I-REL
differences	NNS	I-REL
with	IN	O
respect	NN	O
to	TO	O
gender	VB	O
or	CC	O
sexual	JJ	O
orientation	NN	O

We	PRP	O
could	MD	O
therefore	RB	O
detect	VB	O
no	DT	B-REL
difference	NN	I-REL
in	IN	O
activation	NN	O
patterns	NNS	O
between	IN	O
these	DT	O
groups	NNS	O

There	EX	O
are	VBP	O
no	DT	B-REL
differences	NNS	I-REL
between	IN	O
heterosexuals	NNS	O
and	CC	O
homosexuals	NNS	O
or	CC	O
between	IN	O
women	NNS	O
and	CC	O
men	NNS	O
in	IN	O
terms	NNS	O
of	IN	O
the	DT	O
brain	NN	O
systems	NNS	O
regulating	VBG	O
romantic	JJ	O
love	NN	O

Falling	VBG	O
in	IN	O
love	NN	O
sets	NNS	O
brain	NN	O
circuits	NNS	O
racing	VBG	O
in	IN	O
the	DT	O
same	JJ	O
way	NN	O
,	,	O
regardless	RB	B-REL
of	IN	I-REL
sex	NN	O
or	CC	O
sexual	JJ	O
orientation	NN	O

brains	NNS	O
are	VBP	O
wired	VBN	O
exactly	RB	B-REL
the	DT	I-REL
same	JJ	I-REL
way	NN	I-REL
when	WRB	O
it	PRP	O
comes	VBZ	O
to	TO	O
love	VB	O

the	DT	O
biological	JJ	O
plausibility	NN	O
of	IN	O
a	DT	B-REL
causal	JJ	I-REL
link	NN	I-REL
between	IN	O
increased	VBN	O
time	NN	O
spent	VBN	O
in	IN	O
thermal	JJ	O
comfort	NN	O
and	CC	O
increased	VBD	O
adiposity	NN	O
in	IN	O
the	DT	O
population	NN	O

Reduced	VBN	O
exposure	NN	O
to	TO	O
seasonal	JJ	O
cold	NN	O
may	MD	B-REL
have	VB	I-REL
a	DT	I-REL
dual	JJ	I-REL
effect	NN	I-REL
on	IN	I-REL
energy	NN	O
expenditure	NN	O
,	,	O
both	CC	O
minimizing	VBG	O
the	DT	O
need	NN	O
for	IN	O
physiological	JJ	O
thermogenesis	NN	O
and	CC	O
reducing	VBG	O
thermogenic	JJ	O
capacity	NN	O

Increases	NNS	O
in	IN	O
winter	NN	O
indoor	JJ	O
temperatures	NNS	O
in	IN	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
,	,	O
United	NNP	O
States	NNPS	O
and	CC	O
other	JJ	O
developed	JJ	O
countries	NNS	O
may	MD	B-REL
be	VB	I-REL
contributing	VBG	I-REL
to	TO	I-REL
rises	NNS	O
in	IN	O
obesity	NN	O

central	JJ	O
heating	NN	O
is	VBZ	B-REL
making	VBG	I-REL
you	PRP	O
fat	JJ	O

For	IN	O
modern	JJ	O
living	NN	O
with	IN	O
the	DT	O
central	JJ	O
heating	NN	O
turned	VBD	O
up	RP	O
and	CC	O
efficient	JJ	O
double	JJ	O
glazing	NN	O
preventing	VBG	O
cold	JJ	O
draughts	NNS	O
are	VBP	B-REL
helping	VBG	I-REL
to	TO	O
send	VB	O
obesity	NN	O
rates	NNS	O
soaring	VBG	O

Having	VBG	O
your	PRP$	O
central	JJ	O
heating	NN	O
on	IN	O
can	MD	B-REL
lead	VB	I-REL
to	TO	I-REL
a	DT	O
lack	NN	O
of	IN	O
physical	JJ	O
activity	NN	O
,	,	O
which	WDT	O
can	MD	O
lead	VB	O
to	TO	O
obesity	NN	O

noninformative	JJ	O
vision	NN	O
of	IN	O
one	CD	O
's	POS	O
own	JJ	O
body	NN	O
has	VBZ	B-REL
an	DT	I-REL
analgesic	JJ	I-REL
effect	NN	I-REL
on	IN	I-REL
pain	NN	O
perception	NN	O

pain	NN	O
perception	NN	O
depends	VBZ	B-REL
on	IN	I-REL
multisensory	JJ	O
representations	NNS	O
of	IN	O
the	DT	O
body	NN	O

Simply	RB	O
looking	VBG	O
at	IN	O
your	PRP$	O
body	NN	O
reduces	VBZ	B-REL
pain	NN	O

looking	VBG	O
at	IN	O
your	PRP$	O
body	NN	O
-	:	O
in	IN	O
this	DT	O
case	NN	O
the	DT	O
hand	NN	O
-	:	O
reduces	VBZ	B-REL
the	DT	O
pain	NN	O
experienced	VBD	O

disrupting	VBG	O
the	DT	O
processes	NNS	O
by	IN	O
which	WDT	O
the	DT	O
brain	NN	O
localises	VBZ	O
a	DT	O
noxious	JJ	O
stimulus	NN	O
reduces	VBZ	B-REL
the	DT	O
pain	NN	O
evoked	VBN	O
by	IN	O
that	DT	O
stimulus	NN	O

impeding	VBG	O
the	DT	O
processes	NNS	O
by	IN	O
which	WDT	O
the	DT	O
brain	NN	O
localises	VBZ	O
a	DT	O
noxious	JJ	O
stimulus	NN	O
can	MD	B-REL
reduce	VB	I-REL
pain	NN	O

Crossing	VBG	O
your	PRP$	O
arms	NNS	O
reduces	VBZ	B-REL
the	DT	O
intensity	NN	O
of	IN	O
pain	NN	O

Crossing	VBG	O
your	PRP$	O
arms	NNS	O
`	``	O
relieves	VBZ	B-REL
hand	NN	O
pain	NN	O
'	''	O

maternal	JJ	O
smoking	NN	O
in	IN	O
pregnancy	NN	O
is	VBZ	B-REL
an	DT	I-REL
important	JJ	I-REL
risk	NN	I-REL
factor	NN	I-REL
for	IN	O
several	JJ	O
major	JJ	O
birth	NN	O
defects	NNS	O

Birth	NN	O
defects	NNS	O
that	WDT	O
are	VBP	B-REL
positively	RB	I-REL
associated	VBN	I-REL
with	IN	I-REL
maternal	JJ	O
smoking	NN	O

birth	NN	O
defects	NNS	O
found	VBN	O
to	TO	O
be	VB	B-REL
associated	VBN	I-REL
with	IN	I-REL
smoking	NN	O
during	IN	O
pregnancy	NN	O

Birth	NN	O
defects	NNS	O
linked	VBN	B-REL
for	IN	O
first	JJ	O
time	NN	O
to	TO	O
smoking	NN	O
in	IN	O
pregnancy	NN	O

Women	NNS	O
who	WP	O
smoke	VBP	O
while	IN	O
pregnant	JJ	O
should	MD	O
be	VB	O
aware	JJ	O
that	IN	O
they	PRP	O
are	VBP	O
increasing	VBG	B-REL
the	DT	O
chance	NN	O
their	PRP$	O
baby	NN	O
will	MD	O
be	VB	O
born	VBN	O
malformed	JJ	O

The	DT	O
antibody	NN	O
titre	NN	O
produced	VBN	O
against	IN	O
the	DT	O
glycoprotein-B	NN	O
protein	NN	O
contained	VBD	O
in	IN	O
the	DT	O
vaccine	NN	O
was	VBD	B-REL
signifi	JJ	I-REL
cantly	RB	I-REL
increased	VBN	I-REL
1	CD	O
month	NN	O
after	IN	O
the	DT	O
second	JJ	O
injection	NN	O
in	IN	O
patients	NNS	O
given	VBN	O
the	DT	O
vaccine	NN	O
compared	VBN	O
with	IN	O
those	DT	O
given	VBN	O
placebo	NN	O

humoral	JJ	O
immunity	NN	O
has	VBZ	B-REL
a	DT	I-REL
role	NN	I-REL
in	IN	I-REL
reduction	NN	I-REL
of	IN	O
cytomegalovirus	NN	O
viraemia	NN	O

vaccine	NN	O
preparation	NN	O
moderated	VBD	B-REL
the	DT	O
severity	NN	O
of	IN	O
CMV	NN	O
infection	NN	O

The	DT	O
results	NNS	O
of	IN	O
this	DT	O
study	NN	O
indicate	VBP	O
that	IN	O
players	NNS	O
of	IN	O
RPS	NNS	O
tend	VBP	B-REL
to	TO	I-REL
imitate	VB	I-REL
their	PRP$	O
opponents	NNS	O
,	,	O
in	IN	O
spite	NN	O
of	IN	O
the	DT	O
costs	NNS	O
associated	VBN	O
with	IN	O
imitation	NN	O
in	IN	O
this	DT	O
game	NN	O

the	DT	O
execution	NN	O
of	IN	O
either	CC	O
a	DT	O
rock	NN	O
or	CC	O
scissors	NNS	O
gesture	NN	O
by	IN	O
the	DT	O
blind	JJ	O
player	NN	O
was	VBD	B-REL
predictive	JJ	O
of	IN	O
an	DT	O
imitative	JJ	O
response	NN	O
by	IN	O
the	DT	O
sighted	VBN	O
player	NN	O

Players	NNS	O
of	IN	O
the	DT	O
game	NN	O
rock	NN	O
paper	NN	O
scissors	NNS	O
subconsciously	RB	O
copy	VBP	O
each	DT	O
other	JJ	O
's	POS	O
hand	NN	O
shapes	NNS	O
,	,	O
significantly	RB	B-REL
increasing	VBG	I-REL
the	DT	O
chance	NN	O
of	IN	O
the	DT	O
game	NN	O
ending	VBG	O
in	IN	O
a	DT	O
draw	NN	O

this	DT	O
activity	NN	O
only	RB	O
affected	VBD	B-REL
memory	NN	O
encoding	NN	O
in	IN	O
women	NNS	O

anticipatory	JJ	O
processes	NNS	O
influence	VBP	B-REL
the	DT	O
way	NN	O
in	IN	O
which	WDT	O
women	NNS	O
encode	VBP	O
negative	JJ	O
events	NNS	O
into	IN	O
memory	NN	O

Men	NN	O
and	CC	O
women	NNS	O
differ	VBP	B-REL
in	IN	O
the	DT	O
way	NN	O
they	PRP	O
anticipate	VBP	O
an	DT	O
unpleasant	JJ	O
emotional	JJ	O
experience	NN	O

HOW	NNP	O
WOMEN	NNP	O
'S	POS	O
BRAINS	NNS	O
MAKE	VBP	B-REL
THEM	NNP	O
MORE	JJR	O
LIKELY	NN	O
TO	TO	O
BE	VB	O
TERRIFIED	JJ	O

Women	NNP	O
's	POS	O
brains	NNS	O
`	``	O
make	VBP	O
them	PRP	O
more	RBR	O
scared	VBN	O
during	IN	O
horror	NN	O
movies	NNS	O
'	POS	O

Neural	JJ	O
activation	NN	O
by	IN	O
peripheral	JJ	O
tactile	JJ	O
and	CC	O
noxious	JJ	O
stimulation	NN	O
occurs	VBZ	O
from	IN	O
an	DT	O
early	JJ	O
preterm	JJ	O
stage	NN	O
but	CC	O
that	IN	O
there	EX	O
is	VBZ	O
a	DT	O
change	NN	B-REL
in	IN	O
the	DT	O
pattern	NN	O
and	CC	O
specificity	NN	O
of	IN	O
the	DT	O
response	NN	O
with	IN	O
age	NN	O

specific	JJ	O
neural	JJ	O
circuits	NNS	O
necessary	JJ	O
for	IN	O
discrimination	NN	O
between	IN	O
touch	NN	O
and	CC	O
nociception	NN	O
emerge	VBP	B-REL
from	IN	O
35-37	CD	O
weeks	NNS	O

Babies	NNS	O
can	MD	B-REL
distinguish	VB	I-REL
painful	JJ	O
stimuli	NNS	O
as	IN	O
different	JJ	O
from	IN	O
general	JJ	O
touch	NN	O
from	IN	O
around	IN	O
35-37	CD	O
weeks	NNS	O
gestation	NN	O

After	IN	O
35-37	CD	O
weeks	NNS	O
the	DT	O
response	NN	O
switch	NN	B-REL
to	TO	I-REL
activity	NN	O
in	IN	O
specific	JJ	O
brain	NN	O
areas	NNS	O

Babies	NNS	O
can	MD	B-REL
feel	VB	O
pain	NN	O
two	CD	O
weeks	NNS	O
before	IN	O
they	PRP	O
are	VBP	O
born	VBN	O

Fetuses	NNS	O
can	MD	B-REL
tell	VB	I-REL
the	DT	I-REL
difference	NN	I-REL
between	IN	I-REL
pain	NN	O
and	CC	O
touch	NN	O

...	:	O
high	JJ	O
coronary	JJ	O
collateralization	NN	O
indicates	VBZ	B-REL
a	DT	I-REL
reduced	VBN	I-REL
mortality	NN	O
risk	NN	O
...	:	O

...	:	O
patients	NNS	O
with	IN	O
high	JJ	O
collateralization	NN	O
have	VBP	O
a	DT	O
36	CD	O
%	NN	O
reduced	VBD	B-REL
mortality	NN	O
risk	NN	O
...	:	O

...	:	O
small	JJ	O
bypass	NN	O
vessels	NNS	O
which	WDT	O
act	VBP	O
as	IN	O
a	DT	B-REL
`	``	O
back-up	JJ	O
system	NN	O
'	''	O
for	IN	O
the	DT	O
heart	NN	O
's	POS	O
main	JJ	O
arteries	NNS	O
play	VBP	B-REL
a	DT	O
significant	JJ	B-REL
role	NN	I-REL
in	IN	O
reducing	VBG	O
the	DT	O
mortality	NN	O
of	IN	O
patients	NNS	O
...	:	O

...	:	O
the	DT	O
heart	NN	O
has	VBZ	O
its	PRP$	O
own	JJ	O
back	RB	O
up	IN	O
system	NN	O
to	TO	O
help	VB	B-REL
it	PRP	I-REL
function	VB	O
...	:	O

...	:	O
tiny	JJ	O
blood	NN	O
vessels	NNS	O
that	WDT	O
provide	VBP	O
a	DT	O
back	RB	O
up	RB	O
system	NN	O
for	IN	O
th	DT	O
heaart	JJ	O
help	NN	B-REL
people	NNS	O
survive	VBP	O
heart	NN	O
attacks	NNS	O
...	:	O

...	:	O
As	IN	O
predicted	VBN	O
,	,	O
children	NNS	O
and	CC	O
adolescents	NNS	O
with	IN	O
thinner	JJR	O
parents	NNS	O
-LRB-	-LRB-	O
eg	FW	O
,	,	O
both	DT	O
parents	NNS	O
below	IN	O
the	DT	O
50th	JJ	O
percentile	NN	O
of	IN	O
the	DT	O
healthy-weight	JJ	O
group	NN	O
-RRB-	-RRB-	O
were	VBD	B-REL
twice	RB	I-REL
as	RB	I-REL
likely	JJ	I-REL
to	TO	O
be	VB	O
thin	JJ	O
...	:	O

...	:	O
the	DT	O
strongest	JJS	B-REL
predictor	NN	I-REL
of	IN	O
child/adolescent	JJ	O
thinness	NN	O
was	VBD	O
parental	JJ	O
weight	NN	O
status	NN	O
...	:	O

...	:	O
children	NNS	O
with	IN	O
thinner	JJR	O
parents	NNS	O
are	VBP	O
three	CD	B-REL
times	NNS	I-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
be	VB	I-REL
thin	JJ	O
...	:	O

...	:	O
children	NNS	O
whose	WP$	O
parents	NNS	O
are	VBP	O
thin	JJ	O
are	VBP	O
likely	JJ	B-REL
to	TO	I-REL
be	VB	I-REL
very	RB	I-REL
slim	JJ	O
themselves	PRP	O
...	:	O

...	:	O
children	NNS	O
whose	WP$	O
parents	NNS	O
are	VBP	O
thin	JJ	O
are	VBP	O
likely	JJ	B-REL
to	TO	I-REL
be	VB	I-REL
very	RB	I-REL
slim	JJ	O
themselves	PRP	O
...	:	O

Plasma	NN	O
nitrate	NN	O
and	CC	O
nitrite	JJ	O
levels	NNS	O
were	VBD	O
increased	VBN	B-REL
at	IN	O
all	DT	O
altitudes	NNS	O
above	IN	O
1,300	CD	O
m	NN	O
,	,	O
indicative	JJ	O
of	IN	O
elevated	JJ	O
NO	NN	O
production	NN	O

Plasma	NN	O
biomarkers	NNS	O
of	IN	O
NO	NN	O
production	NN	O
-LRB-	-LRB-	O
nitrite	NN	O
,	,	O
nitrate	JJ	O
-RRB-	-RRB-	O
and	CC	O
activity	NN	O
-LRB-	-LRB-	O
cGMP	NN	O
-RRB-	-RRB-	O
are	VBP	O
elevated	JJ	B-REL
on	IN	O
acclimatisation	NN	O
to	TO	O
high	JJ	O
altitude	NN	O

Tibetans	NNS	O
living	VBG	O
on	IN	O
Everest	NNP	O
found	VBD	O
they	PRP	O
produced	VBD	B-REL
more	JJR	I-REL
of	IN	O
the	DT	O
chemical	NN	O

...	:	O
angry	JJ	O
faces	NNS	O
,	,	O
a	DT	O
biologically	RB	O
salient	JJ	O
threat	NN	O
cue	NN	O
,	,	O
elicited	VBD	B-REL
increased	VBN	I-REL
activation	NN	I-REL
in	IN	O
bilateral	JJ	O
AI	NN	O
and	CC	O
the	DT	O
amygdala	NN	O
in	IN	O
maltreated	JJ	O
children	NNS	O
exposed	VBN	O
to	TO	O
family	NN	O
violence	NN	O
...	:	O

...	:	O
children	NNS	O
exposed	VBN	O
to	TO	O
family	NN	O
violence	NN	O
-LRB-	-LRB-	O
with	IN	O
normative	JJ	O
levels	NNS	O
of	IN	O
anxiety	NN	O
-RRB-	-RRB-	O
show	VBP	B-REL
increased	VBN	I-REL
AI	NNP	O
and	CC	O
amygdala	NN	O
reactivity	NN	O
in	IN	O
response	NN	O
to	TO	O
angry	JJ	O
but	CC	O
not	RB	O
sad	JJ	O
faces	NNS	O
...	:	O

...	:	O
exposure	NN	O
to	TO	O
family	NN	O
violence	NN	O
was	VBD	B-REL
associated	VBN	I-REL
with	IN	I-REL
increased	VBN	O
brain	NN	O
activity	NN	O
in	IN	O
two	CD	O
specific	JJ	O
brain	NN	O
areas	NNS	O
-LRB-	-LRB-	O
the	DT	O
anterior	JJ	O
insula	NN	O
and	CC	O
the	DT	O
amygdala	NN	O
-RRB-	-RRB-	O
when	WRB	O
children	NNS	O
viewed	VBD	O
pictures	NNS	O
of	IN	O
angry	JJ	O
faces	NNS	O
...	:	O

In	IN	O
both	DT	O
cases	NNS	O
the	DT	O
brain	NN	O
becomes	VBZ	B-REL
increasingly	RB	I-REL
wary	JJ	I-REL
of	IN	I-REL
potential	JJ	O
threats	NNS	O
...	:	O

In	IN	O
both	DT	O
cases	NNS	O
,	,	O
the	DT	B-REL
brain	NN	I-REL
becomes	VBZ	I-REL
on	IN	I-REL
guard	NN	I-REL
for	IN	I-REL
threats	NNS	O
...	:	O

...	:	O
Scans	NNS	O
revealed	VBD	O
abused	JJ	O
youngsters	NNS	O
became	VBD	B-REL
more	RBR	I-REL
``	``	I-REL
tuned	VBN	I-REL
''	''	I-REL
to	TO	I-REL
danger	NN	O
but	CC	O
they	PRP	O
were	VBD	O
also	RB	O
more	RBR	O
likely	JJ	O
to	TO	O
suffer	VB	O
depression	NN	O
...	:	O

...	:	O
when	WRB	O
they	PRP	O
saw	VBD	O
angry	JJ	O
faces	NNS	O
,	,	O
the	DT	O
maltreated	JJ	O
children	NNS	O
showed	VBD	B-REL
extra	JJ	I-REL
activity	NN	I-REL
in	IN	O
the	DT	O
amygdala	NN	O
...	:	O

...	:	O
child	NN	O
abuse	NN	O
changes	VBZ	B-REL
the	DT	I-REL
brain	NN	I-REL
...	:	O

...	:	O
When	WRB	O
children	NNS	O
have	VBP	O
been	VBN	O
exposed	VBN	O
to	TO	O
family	NN	O
abuse	NN	O
,	,	O
their	PRP$	O
brains	NNS	O
become	VBP	O
`	``	O
tuned	VBN	B-REL
'	''	I-REL
for	IN	O
threats	NNS	O
...	:	O

...	:	O
we	PRP	O
found	VBD	O
three	CD	B-REL
additional	JJ	I-REL
significant	JJ	I-REL
signals	NNS	I-REL
of	IN	I-REL
association	NN	I-REL
with	IN	O
CD	NNP	O
...	:	O

...	:	O
we	PRP	O
find	VBP	O
associations	NNS	B-REL
with	IN	I-REL
the	DT	I-REL
IRF8	NN	I-REL
region	NN	I-REL
and	CC	I-REL
the	DT	O
region	NN	O
containing	VBG	B-REL
CDH1	NN	O
and	CC	O
CDH3	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
substantial	JJ	O
phenotypic	JJ	O
and	CC	O
genetic	JJ	O
heterogeneity	NN	O
for	IN	O
CD	NNP	O
itself	PRP	O
...	:	O

single	JJ	O
peripheral	JJ	O
-	:	O
vein	NN	O
infusion	NN	O
of	IN	O
our	PRP$	O
scAAV2/8-LP	NN	O
1-hFIXco	NN	O
vector	NN	O
consistently	RB	B-REL
leads	VBZ	I-REL
to	TO	I-REL
long-term	JJ	O
expression	NN	O
of	IN	O
the	DT	O
FIX	NNP	O
transgene	NN	O
at	IN	O
therapeutic	JJ	O
levels	NNS	O

Peripheral-vein	JJ	O
infusion	NN	O
of	IN	O
scAAV2/8-LP	NN	O
1-hFIXco	NN	O
resulted	VBD	B-REL
in	IN	I-REL
FIX	NNP	O
transgene	NN	O
expression	NN	O
at	IN	O
levels	NNS	O
sufficient	JJ	O
to	TO	O
improve	VB	O
the	DT	O
bleeding	NN	O
phenotype	NN	O

adults	NNS	O
with	IN	O
haemophilia	NN	O
B	NN	O
benefit	NN	B-REL
from	IN	O
treatment	NN	O
,	,	O
reducing	VBG	O
need	NN	O
for	IN	O
injections	NNS	O
with	IN	O
clotting	NN	O
factor	NN	O
to	TO	O
prevent	VB	O
bleeds	NNS	O

Haemophilia	NNP	O
gene	NN	O
therapy	NN	O
shows	VBZ	B-REL
early	JJ	I-REL
success	NN	I-REL

the	DT	O
closure	NN	O
of	IN	O
local	JJ	O
schools	NNS	O
is	VBZ	O
likely	JJ	B-REL
to	TO	I-REL
have	VB	I-REL
a	DT	I-REL
very	RB	I-REL
targeted	VBN	I-REL
impact	NN	I-REL
on	IN	I-REL
the	DT	O
peak	JJ	O
demand	NN	O

only	RB	O
widespread	JJ	O
school	NN	O
closures	NNS	O
are	VBP	B-REL
sufficient	JJ	I-REL
to	TO	I-REL
mitigate	VB	O
the	DT	O
burden	NN	O
on	IN	O
the	DT	O
worst-affected	JJ	O
hospitals	NNS	O

only	RB	O
significant	JJ	O
widespread	JJ	O
school	NN	O
closures	NNS	O
would	MD	B-REL
have	VB	I-REL
real	JJ	I-REL
effect	NN	I-REL
on	IN	I-REL
the	DT	O
spread	NN	O
of	IN	O
a	DT	O
epidemic	JJ	O
and	CC	O
the	DT	O
strain	NN	O
placed	VBN	O
on	IN	O
hospital	NN	O
intensive	JJ	O
care	NN	O
units	NNS	O

Widespread	JJ	O
closures	NNS	O
of	IN	O
schools	NNS	O
are	VBP	B-REL
necessary	JJ	I-REL
to	TO	I-REL
reduce	VB	I-REL
the	DT	O
burden	NN	O
on	IN	O
hospitals	NNS	O
during	IN	O
flu	NN	O
pandemics	NNS	O

in	FW	O
vitro	FW	O
invasion	NN	O
was	VBD	B-REL
significantly	RB	I-REL
attenuated	VBN	I-REL
by	IN	O
sera	NNS	O
from	IN	O
PCOS	NN	O
women	NNS	O
after	IN	O
6	CD	O
months	NNS	O
of	IN	O
metformin	NN	O
treatment	NN	O

In	FW	O
vitro	FW	O
invasion	NN	O
in	IN	O
ECC-1	NN	O
cells	NNS	O
was	VBD	B-REL
significantly	RB	I-REL
attenuated	VBN	I-REL
by	IN	O
sera	NNS	O
from	IN	O
PCOS	NN	O
women	NNS	O
after	IN	O
6	CD	O
months	NNS	O
of	IN	O
metformin	NN	O
treatment	NN	O

a	DT	O
drug	NN	O
treatment	NN	O
used	VBN	O
to	TO	O
treat	VB	O
diabetes	NN	O
and	CC	O
also	RB	O
women	NNS	O
with	IN	O
Polycystic	JJ	O
Ovary	NN	O
syndrome	NN	O
-LRB-	-LRB-	O
PCOS	NN	O
-RRB-	-RRB-	O
,	,	O
may	MD	B-REL
potentially	RB	I-REL
provide	VB	I-REL
protection	NN	O
against	IN	O
endometrial	JJ	O
cancer	NN	O

these	DT	O
results	NNS	O
revealed	VBD	B-REL
a	DT	I-REL
domain-general	JJ	I-REL
sex	NN	I-REL
difference	NN	I-REL
in	IN	O
vagueness	NN	O

Men	NN	O
and	CC	O
women	NNS	O
appear	VBP	B-REL
to	TO	I-REL
categorize	VB	I-REL
the	DT	O
same	JJ	O
common	JJ	O
objects	NNS	O
in	IN	O
systematically	RB	O
different	JJ	O
ways	NNS	O

men	NNS	O
tend	VBP	B-REL
to	TO	I-REL
make	VB	I-REL
black-or-white	JJ	O
judgements	NNS	O
when	WRB	O
women	NNS	O
are	VBP	O
more	RBR	O
prone	JJ	O
to	TO	O
see	VB	O
shades	NNS	O
of	IN	O
grey	JJ	O
in	IN	O
choices	NNS	O
and	CC	O
decisions	NNS	O

OUR	NN	O
abilities	NNS	O
to	TO	O
make	VB	O
decisions	NNS	O
may	MD	B-REL
be	VB	I-REL
governed	VBN	I-REL
by	IN	I-REL
gender	NN	O

Those	DT	O
dark	JJ	O
contrasts	VBZ	O
may	MD	B-REL
in	IN	I-REL
turn	NN	I-REL
increase	VBP	I-REL
the	DT	I-REL
risk	NN	I-REL
of	IN	O
suicide	NN	O

level	NN	O
of	IN	O
others	NNS	O
'	POS	O
happiness	NN	O
may	MD	B-REL
be	VB	I-REL
a	DT	I-REL
risk	NN	I-REL
factor	NN	I-REL
for	IN	O
suicide	NN	O

The	DT	O
happiest	JJS	O
countries	NNS	O
and	CC	O
happiest	JJS	O
U.S.	NNP	O
states	NNS	O
tend	VBP	B-REL
to	TO	I-REL
have	VB	I-REL
the	DT	O
highest	JJS	O
suicide	NN	O
rates	NNS	O

People	NNS	O
who	WP	O
live	VBP	O
in	IN	O
``	``	O
happy	JJ	O
''	''	O
countries	NNS	O
are	VBP	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
commit	VB	O
suicide	NN	O

Regulatory	JJ	O
problems	NNS	O
in	IN	O
infancy	NN	O
can	MD	B-REL
increase	VB	I-REL
the	DT	I-REL
likelihood	NN	I-REL
of	IN	O
developing	VBG	O
behavioural	JJ	O
problems	NNS	O
in	IN	O
childhood	NN	O

children	NNS	O
with	IN	O
previous	JJ	O
regulatory	JJ	O
problems	NNS	B-REL
have	VBP	B-REL
more	RBR	I-REL
behavioural	JJ	I-REL
problems	NNS	O
than	IN	B-REL
controls	NNS	O

Infants	NNS	O
who	WP	O
have	VBP	O
problems	NNS	O
with	IN	O
persistent	JJ	O
crying	VBG	O
,	,	O
sleeping	VBG	O
and/or	CC	O
feeding	VBG	O
-	:	O
known	VBN	O
as	IN	O
regulatory	JJ	O
problems	NNS	O
-	:	O
are	VBP	O
far	RB	B-REL
more	RBR	I-REL
likely	JJ	I-REL
to	TO	I-REL
become	VB	I-REL
children	NNS	O
with	IN	O
significant	JJ	O
behavioural	JJ	O
problems	NNS	O

STRESSED-OUT	JJ	O
BABIES	NNS	O
CAN	VBP	B-REL
BECOME	VB	I-REL
PROBLEM	NN	O
KIDS	NNS	O

Excessive	JJ	O
crying	VBG	O
as	IN	O
a	DT	O
baby	NN	O
may	MD	B-REL
hint	VB	I-REL
at	IN	O
behavioural	JJ	O
problems	NNS	O
later	RB	O
in	IN	O
life	NN	O

Over	IN	O
the	DT	O
past	JJ	O
30	CD	O
years	NNS	O
there	RB	O
have	VBP	B-REL
been	VBN	I-REL
substantial	JJ	I-REL
reductions	NNS	I-REL
in	IN	O
deaths	NNS	O
from	IN	O
assault	NN	O
in	IN	O
infants	NNS	O
and	CC	O
children	NNS	O

rates	NNS	O
of	IN	O
violent	JJ	O
death	NN	O
in	IN	O
infancy	NN	O
and	CC	O
middle	JJ	O
childhood	NN	O
have	VBP	B-REL
fallen	VBN	I-REL
over	IN	I-REL
the	DT	O
past	JJ	O
30	CD	O
years	NNS	O

The	DT	O
number	NN	O
of	IN	O
children	NNS	O
dying	VBG	O
a	DT	O
violent	JJ	O
death	NN	O
has	VBZ	B-REL
fallen	VBN	I-REL
substantially	RB	I-REL
in	IN	O
England	NNP	O
and	CC	O
Wales	NNP	O
over	IN	O
the	DT	O
past	JJ	O
30	CD	O
years	NNS	O

MG	NN	O
modification	NN	O
of	IN	O
LDL	NN	O
...	:	O
may	MD	B-REL
explain	VB	I-REL
the	DT	I-REL
escalation	NN	I-REL
of	IN	O
cardiovascular	JJ	O
risk	NN	O
in	IN	O
diabetes	NN	O
and	CC	O
the	DT	O
cardioprotective	JJ	O
effect	NN	O
of	IN	O
metformin	NN	O

newly	RB	O
found	VBN	O
form	NN	O
of	IN	O
cholesterol	NN	O
seems	VBZ	O
to	TO	B-REL
be	VB	O
`	``	O
ultra-bad	NN	O
'	''	O
,	,	O
leading	VBG	B-REL
to	TO	O
increased	VBN	B-REL
risk	NN	I-REL
of	IN	O
heart	NN	O
disease	NN	O

5	CD	O
g	NN	O
per	IN	O
day	NN	O
higher	JJR	O
salt	NN	O
intake	NN	O
-LRB-	-LRB-	O
2000	CD	O
mg	NN	O
of	IN	O
sodium	NN	O
-RRB-	-RRB-	O
is	VBZ	B-REL
associated	VBN	I-REL
with	IN	I-REL
a	DT	O
17	CD	O
%	NN	O
greater	JJR	O
risk	NN	O
of	IN	O
total	JJ	O
cardiovascular	JJ	O
disease	NN	O
,	,	O
and	CC	O
,	,	O
crucially	RB	O
a	DT	O
23	CD	O
%	NN	O
greater	JJR	O
risk	NN	O
of	IN	O
stroke	NN	O

High	JJ	O
dietary	JJ	O
salt	NN	O
has	VBZ	B-REL
detrimental	JJ	I-REL
effects	NNS	I-REL
on	IN	I-REL
blood	NN	O
pressure	NN	O
and	CC	O
cardiovascular	JJ	O
outcomes	NNS	O

lowering	VBG	O
dietary	JJ	O
salt	NN	O
intake	NN	O
has	VBZ	B-REL
the	DT	I-REL
potential	JJ	I-REL
to	TO	I-REL
save	VB	I-REL
millions	NNS	O
of	IN	O
lives	NNS	O
globally	RB	O
by	IN	O
substantially	RB	O
reducing	VBG	O
levels	NNS	O
of	IN	O
heart	NN	O
disease	NN	O
and	CC	O
strokes	NNS	O

CUTTING	VBG	O
salt	NN	O
consumption	NN	O
by	IN	O
just	RB	O
half	PDT	O
a	DT	O
teaspoon	NN	O
a	DT	O
day	NN	O
could	MD	B-REL
save	VB	I-REL
20,000	CD	O
lives	NNS	O

REDUCING	VBG	O
salt	NN	O
intake	NN	O
by	IN	O
a	DT	O
third	JJ	O
would	MD	B-REL
save	VB	I-REL
millions	NNS	O
of	IN	O
lives	NNS	O
worldwide	RB	O

Cutting	VBG	O
salt	NN	O
consumption	NN	O
by	IN	O
half	PDT	O
a	DT	O
teaspoon	NN	O
a	DT	O
day	NN	O
could	MD	B-REL
save	VB	I-REL
20,000	CD	O
lives	NNS	O
every	DT	O
year	NN	O

15	CD	O
%	NN	O
cut	NN	O
in	IN	O
consumption	NN	O
could	MD	B-REL
save	VB	I-REL
8.5	CD	O
million	CD	O
lives	NNS	O

Cutting	VBG	O
salt	NN	O
intake	NN	O
by	IN	O
just	RB	O
half	PDT	O
a	DT	O
teaspoon	NN	O
a	DT	O
day	NN	O
could	MD	B-REL
save	VB	I-REL
20,000	CD	O
lives	NNS	O

our	PRP$	O
approach	NN	O
has	VBZ	O
identified	VBN	O
the	DT	B-REL
so-called	JJ	O
`	``	O
hate	VB	O
circuit	NN	O
'	''	O
,	,	O
as	IN	O
the	DT	O
one	CD	O
showing	VBG	B-REL
the	DT	O
largest	JJS	B-REL
change	NN	I-REL
in	IN	O
both	CC	O
FEMDD	NN	O
and	CC	O
RMDD	NN	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
involvement	NN	B-REL
of	IN	O
the	DT	O
`	``	O
hate	NN	O
circuit	NN	O
'	''	O
in	IN	O
depression	NN	O

depression	NN	O
uncouples	NNS	B-REL
brain	NN	O
's	POS	O
hate	NN	O
circuit	NN	O

...	:	O
both	DT	O
groups	NNS	O
made	VBD	B-REL
similar	JJ	I-REL
progress	NN	I-REL
in	IN	I-REL
reading	NN	I-REL
and	CC	I-REL
the	DT	I-REL
Steiner	NNP	I-REL
group	NN	I-REL
performed	VBD	I-REL
worse	JJR	I-REL
in	IN	O
spelling	NN	O
...	:	O

...	:	O
the	DT	O
young	JJ	O
children	NNS	O
showed	VBD	B-REL
similar	JJ	I-REL
,	,	I-REL
and	CC	I-REL
in	IN	I-REL
some	DT	I-REL
cases	NNS	I-REL
better	JJR	I-REL
progress	NN	I-REL
in	IN	O
literacy	NN	O
...	:	O

...	:	O
children	NNS	O
taugt	VBP	O
to	TO	O
read	VB	O
at	IN	B-REL
seven	CD	O
still	RB	B-REL
learn	VB	I-REL
at	IN	O
the	DT	B-REL
same	JJ	I-REL
pace	NN	I-REL
as	IN	O
a	DT	O
four	CD	O
year	NN	O
old	JJ	O
...	:	O

deregulation	NN	O
of	IN	O
a	DT	O
single	JJ	O
kinase	NN	O
in	IN	O
two	CD	O
distinct	JJ	O
cellular	JJ	O
compartments	NNS	O
of	IN	O
the	DT	O
endometrium	NN	O
,	,	O
the	DT	O
luminal	JJ	O
epithelium	NN	O
and	CC	O
underlying	VBG	O
stroma	NN	O
,	,	O
is	VBZ	O
intricately	RB	B-REL
linked	VBN	I-REL
to	TO	O
subsequent	JJ	O
implantation	NN	O
failure	NN	O
and	CC	O
miscarriage	NN	O
,	,	O
respectively	RB	O

deregulated	VBN	O
SGK1	NN	O
activity	NN	O
in	IN	O
cycling	NN	O
endometrium	NN	O
interferes	VBZ	B-REL
with	IN	O
embryo	NN	O
implantation	NN	O
,	,	O
leading	VBG	O
to	TO	O
infertility	NN	O

Enzyme	NN	O
identified	VBD	O
as	IN	O
possible	JJ	B-REL
reason	NN	I-REL
for	IN	O
multiple	JJ	O
miscarriage	NN	O
and	CC	O
infertility	NN	O

The	DT	O
protein	NN	O
SGK1	NN	O
in	IN	O
the	DT	O
lining	NN	O
of	IN	O
the	DT	O
womb	NN	O
makes	VBZ	B-REL
it	PRP	I-REL
harder	JJR	I-REL
to	TO	O
get	VB	O
pregnant	JJ	O

SGK1	NN	O
linked	VBN	B-REL
to	TO	O
infertility	NN	O

fertility	NN	O
switch	NN	O
can	MD	B-REL
stop	VB	I-REL
women	NNS	O
getting	VBG	O
pregnancy	NN	O
and	CC	O
cause	VB	O
miscarriages	NNS	O

fertility	NN	O
switch	NN	O
protein	NN	O
which	WDT	O
appears	VBZ	B-REL
to	TO	I-REL
increase	VB	I-REL
infertility	NN	O

High	JJ	O
levels	NNS	O
of	IN	O
a	DT	O
protein	NN	O
called	VBN	O
SGK1	NN	O
are	VBP	O
linked	VBN	B-REL
with	IN	O
infertility	NN	O

many	JJ	O
women	NNS	O
in	IN	O
the	DT	O
UK	NNP	O
are	VBP	O
being	VBG	O
forced	VBN	O
to	TO	O
go	VB	O
back	RB	O
to	TO	O
work	VB	O
full-time	JJ	O
or	CC	O
abandon	VB	O
their	PRP$	O
careers	NNS	O
after	IN	O
having	VBG	O
a	DT	O
child	NN	O
because	IN	B-REL
of	IN	I-REL
a	DT	O
lack	NN	O
of	IN	O
part-time	JJ	O
work	NN	O
,	,	O
particularly	RB	O
those	DT	O
in	IN	O
senior	JJ	O
or	CC	O
highly-paid	JJ	O
roles	NNS	O

association	NN	O
of	IN	O
PP1	NN	O
with	IN	O
the	DT	O
N	NN	O
terminus	NN	O
of	IN	O
Spc7	NN	O
is	VBZ	B-REL
required	VBN	I-REL
for	IN	I-REL
efficient	JJ	O
spindle	NN	O
checkpoint	NN	O
silencing	NN	O

association	NN	O
of	IN	O
type	NN	O
1	CD	O
phosphatase	NN	O
-LRB-	-LRB-	O
PP1Dis2	NN	O
-RRB-	-RRB-	O
with	IN	O
both	CC	O
the	DT	O
N	NN	O
terminus	NN	O
of	IN	O
Spc7	NN	O
and	CC	O
the	DT	O
nonmotor	JJ	O
domains	NNS	O
of	IN	O
the	DT	O
Klp5-Klp6	NN	O
-LRB-	-LRB-	O
kinesin-8	NN	O
-RRB-	-RRB-	O
complex	NN	O
is	VBZ	B-REL
necessary	JJ	I-REL
to	TO	I-REL
counteract	VB	I-REL
Aurora	NNP	I-REL
B	NN	I-REL
kinase	NN	I-REL
to	TO	O
efficiently	RB	B-REL
silence	NN	I-REL
the	DT	O
spindle	NN	O
checkpoint	NN	O

The	DT	O
properties	NNS	O
of	IN	O
N	NN	O
enable	VBP	B-REL
an	DT	O
amphiphilic	JJ	O
,	,	O
environment-dependent	JJ	O
switch	NN	O
that	WDT	O
permits	VBZ	O
interactions	NNS	O
with	IN	O
the	DT	O
CD	NNP	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
OMM	NNP	O

Malonyl-CoA	NN	O
sensitivity	NN	O
is	VBZ	O
coupled	VBN	O
to	TO	O
the	DT	O
properties	NNS	O
of	IN	O
the	DT	O
OMM	NN	O
by	IN	O
Nalpha-OMM	NN	O
associations	NNS	B-REL
that	WDT	O
alter	VBP	O
the	DT	O
Nalpha/Nbeta	NN	O
ratio	NN	O

the	DT	O
enzyme	NN	O
known	VBN	O
as	IN	O
`	``	O
Carnitine	NNP	O
palmitoyltransferase	NN	O
1A	NN	O
'	''	O
-LRB-	-LRB-	O
CPT1	NN	O
-RRB-	-RRB-	O
has	VBZ	O
a	DT	O
switch	NN	O
which	WDT	O
is	VBZ	O
thrown	VBN	O
depending	VBG	B-REL
on	IN	I-REL
the	DT	O
composition	NN	O
and	CC	O
curvature	NN	O
of	IN	O
its	PRP$	O
cellular	JJ	O
membrane	NN	O

We	PRP	O
noted	VBD	O
little	JJ	B-REL
variation	NN	I-REL
between	IN	O
countries	NNS	O
in	IN	O
the	DT	O
rate	NN	O
of	IN	O
maltreatment-related	JJ	O
injury	NN	O
admission	NN	O

Less	RBR	O
than	IN	O
two-fold	JJ	O
variation	NN	B-REL
in	IN	O
violent	JJ	O
deaths	NNS	O
or	CC	O
maltreatment	NN	O

Child	NN	O
abuse	NN	O
rates	NNS	O
have	VBP	B-REL
not	RB	I-REL
declined	VBN	I-REL

...	:	O
manipulating	VBG	O
confidence	NN	O
significantly	RB	B-REL
affected	VBD	I-REL
performance	NN	O
...	:	O

...	:	O
confidence	NN	O
mediates	VBZ	B-REL
the	DT	I-REL
sex	NN	I-REL
difference	NN	I-REL
in	IN	I-REL
mental	JJ	O
rotation	NN	O
performance	NN	O
...	:	O

...	:	O
boosting	VBG	O
a	DT	O
woman	NN	O
's	POS	O
confidence	NN	O
makes	VBZ	B-REL
her	PRP$	I-REL
better	JJR	I-REL
at	IN	I-REL
spatial	JJ	O
tasks	NNS	O
...	:	O

...	:	O
lack	NN	O
of	IN	O
confidence	NN	O
is	VBZ	B-REL
a	DT	I-REL
factor	NN	I-REL
in	IN	I-REL
women	NNS	I-REL
's	POS	I-REL
tendency	NN	I-REL
to	TO	I-REL
struggle	NN	I-REL
in	IN	O
tasks	NNS	B-REL
requiring	VBG	I-REL
spatial	JJ	O
awareness	NN	O
...	:	O

...	:	O
sexist	JJ	O
jokes	NNS	O
make	VBP	B-REL
women	NNS	I-REL
worse	JJR	I-REL
drivers	NNS	O
...	:	O

